(c) 30-day mortality
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
Age | 1.038 | 0.997–1.082 | 0.073 | 1.038 | 0.994–1.085 | 0.094 |
Gender | 1.720 | 0.718–4.124 | 0.224 | |||
BMI (kg/m2) | 1.032 | 0.928–1.147 | 0.564 | |||
ASA score | 1.179 | 0.504–2.762 | 0.704 | |||
| ||||||
Indication of extended hepatectomy | ||||||
Benign liver disease | Reference | Reference | Reference | Reference | Reference |
Reference |
Primary malignancy | 2.406 | 0.239–24.220 |
0.456 | 1.784 |
0.078–40.796 |
0.717 |
Metastatic disease | 3.517 | 1.150–10.754 | 0.027 | 3.460 | 0.856–13.980 | 0.081 |
Preoperative chemotherapy | 0.570 | 0.126–2.568 | 0.464 | |||
Platelet count <150 x 109/L | 5.394 | 1.784–16.311 | 0.003 | 4.430 | 1.055–18.777 | 0.043 |
| ||||||
Intraoperative blood loss (L) | 1.342 | 1.085–1.659 | 0.007 | 1.166 | 0.753–1.805 | 0.492 |
Intraoperative RBC/FFP transfusion | 3.216 | 1.295–7.986 | 0.012 | 1.604 | 0.435–5.921 | 0.478 |
Operation time (hour) | 1.261 | 1.023–1.555 | 0.030 | 1.093 | 0.839–1.425 | 0.509 |
OR: odds ratio; CI: confidence interval; BMI: body mass index; ASA: American Society of Anesthesiologists; RBC: red blood cells; FFP: fresh-frozen plasma.